Standard BioTools Inc (LAB)
1.925
0.00 (0.00%)
USD |
NASDAQ |
Jun 21, 16:00
1.925
0.00 (0.00%)
After-Hours: 20:00
Standard BioTools Cash from Investing (Quarterly): 318.08M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 318.08M |
| December 31, 2023 | -13.12M |
| September 30, 2023 | -49.93M |
| June 30, 2023 | 40.13M |
| March 31, 2023 | 43.15M |
| December 31, 2022 | 40.24M |
| September 30, 2022 | 10.74M |
| June 30, 2022 | -138.24M |
| March 31, 2022 | -0.868M |
| December 31, 2021 | -1.145M |
| September 30, 2021 | -1.706M |
| June 30, 2021 | -4.172M |
| March 31, 2021 | -4.923M |
| December 31, 2020 | -0.822M |
| September 30, 2020 | 13.21M |
| June 30, 2020 | 10.13M |
| March 31, 2020 | 17.46M |
| December 31, 2019 | -0.551M |
| September 30, 2019 | 6.549M |
| June 30, 2019 | -35.54M |
| March 31, 2019 | -9.757M |
| December 31, 2018 | -0.019M |
| September 30, 2018 | 0.802M |
| June 30, 2018 | 4.199M |
| March 31, 2018 | -0.263M |
| Date | Value |
|---|---|
| December 31, 2017 | -3.879M |
| September 30, 2017 | 0.448M |
| June 30, 2017 | 3.589M |
| March 31, 2017 | 17.50M |
| December 31, 2016 | 13.78M |
| September 30, 2016 | 9.821M |
| June 30, 2016 | 0.292M |
| March 31, 2016 | 21.20M |
| December 31, 2015 | 4.844M |
| September 30, 2015 | 17.68M |
| June 30, 2015 | -6.856M |
| March 31, 2015 | 10.07M |
| December 31, 2014 | 5.652M |
| September 30, 2014 | -3.952M |
| June 30, 2014 | -58.85M |
| March 31, 2014 | -121.23M |
| December 31, 2013 | 9.617M |
| September 30, 2013 | -12.06M |
| June 30, 2013 | -27.52M |
| March 31, 2013 | 2.395M |
| December 31, 2012 | -2.443M |
| September 30, 2012 | 5.288M |
| June 30, 2012 | 6.586M |
| March 31, 2012 | 4.57M |
| December 31, 2011 | 4.958M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-138.24M
Minimum
Jun 2022
318.08M
Maximum
Mar 2024
12.43M
Average
-0.6865M
Median
Cash from Investing (Quarterly) Benchmarks
| Bruker Corp | -304.20M |
| Azenta Inc | -270.61M |
| Harvard Bioscience Inc | -0.225M |
| Bionano Genomics Inc | 47.59M |
| Akoya Biosciences Inc | -48.82M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -62.48M |
| Cash from Financing (Quarterly) | -19.73M |
| Free Cash Flow | -99.88M |
| Free Cash Flow Per Share (Quarterly) | -0.2151 |
| Free Cash Flow to Equity (Quarterly) | -54.70M |
| Free Cash Flow to Firm (Quarterly) | -63.26M |
| Free Cash Flow Yield | -39.03% |